Richard Leduc

8.3k total citations
178 papers, 6.5k citations indexed

About

Richard Leduc is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Richard Leduc has authored 178 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 41 papers in Cellular and Molecular Neuroscience and 24 papers in Surgery. Recurrent topics in Richard Leduc's work include Receptor Mechanisms and Signaling (61 papers), Neuropeptides and Animal Physiology (29 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (19 papers). Richard Leduc is often cited by papers focused on Receptor Mechanisms and Signaling (61 papers), Neuropeptides and Animal Physiology (29 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (19 papers). Richard Leduc collaborates with scholars based in Canada, United States and France. Richard Leduc's co-authors include Emanuel Escher, Gaétan Guillemette, Jean‐Bernard Denault, Pierre Lavigne, Jean‐Michel Longpré, Antoine Désilets, Claire M. Dubois, François Blanchette, Marie‐Hélène Laprise and Laurel Thomas and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Richard Leduc

175 papers receiving 6.4k citations

Peers

Countries citing papers authored by Richard Leduc

Since Specialization

Citations

This map shows the geographic impact of Richard Leduc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Leduc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Leduc more than expected).

Fields of papers citing papers by Richard Leduc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Leduc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Leduc. The network helps show where Richard Leduc may publish in the future.

Co-authorship network of co-authors of Richard Leduc

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Leduc. A scholar is included among the top collaborators of Richard Leduc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Leduc. Richard Leduc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants 2025 ·Journal of Medicinal Chemistry ·(unknown), Jimena Pérez‐Vargas, Antoine Désilets, Malihe Hassanzadeh, Connor A.H. Thompson, (unknown), (unknown), Siobhan Ennis, Iván Villanueva, (unknown), (unknown), (unknown), (unknown), Masahiro Niikura, C.H. Arrowsmith, François Jean, Richard Leduc, Pierre‐Luc Boudreault	2
2	Structural basis of TMPRSS11D specificity and autocleavage activation 2025 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Aiping Dong, (unknown), Alma Seitova, Yanjun Li, (unknown), Tristan M. G. Kenney, Linda Z. Penn, A.M. Edwards, Richard Leduc, Pierre‐Luc Boudreault, Gregg B. Morin, François Bénard, C.H. Arrowsmith	3
3	Optimizing the pharmacokinetics and selectivity of TMPRSS2 inhibitors 2025 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Antoine Désilets, (unknown), (unknown), (unknown), Ulrike Froehlich, (unknown), (unknown), François Jean, Philippe Sarret, Richard Leduc, Pierre‐Luc Boudreault	1
4	Structural insights into frog skin-derived cyclic peptides as selective matriptase inhibitors 2025 ·European Journal of Medicinal Chemistry ·Agata Gitlin‐Domagalska, Malihe Hassanzadeh, (unknown), (unknown), (unknown), Antoine Désilets, Dawid Dębowski, Pierre‐Luc Boudreault, Richard Leduc, Krzysztof Rolka	0
5	G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors 2024 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), (unknown), Brian J. Holleran, Charlotte Avet, (unknown), (unknown), Christine Lavoie, Kendra S. Carmon, Michel Bouvier, Richard Leduc	1
6	Rational In Silico Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 Subpocket 2024 ·Journal of Medicinal Chemistry ·(unknown), Antoine Désilets, (unknown), (unknown), (unknown), (unknown), (unknown), Walid Guerrab, Ulrike Froehlich, (unknown), Philippe Sarret, Richard Leduc, Pierre‐Luc Boudreault	6
7	Unraveling allostery within the angiotensin II type 1 receptor for Gα _q and β-arrestin coupling 2023 ·Science Signaling ·(unknown), Wijnand J. C. van der Velden, Yoon Namkung, Anita K. Nivedha, (unknown), (unknown), Brian J. Holleran, (unknown), Richard Leduc, (unknown), Keith Le, S. Bhattacharya, Nagarajan Vaidehi, Stéphane A. Laporte	10
8	Optimization of Ketobenzothiazole‐Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication 2023 ·ChemMedChem ·(unknown), Antoine Désilets, Malihe Hassanzadeh, (unknown), (unknown), (unknown), (unknown), Alexandre Murza, François Jean, Éric Marsault, Martin Richter, Richard Leduc, Pierre‐Luc Boudreault	6
9	Convergent selective signaling impairment exposes the pathogenicity of latrophilin-3 missense variants linked to inheritable ADHD susceptibility 2022 ·Molecular Psychiatry ·(unknown), Brian J. Holleran, (unknown), (unknown), (unknown), (unknown), Richard Leduc, Antony A. Boucard	10
10	Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors 2018 ·Science Signaling ·Yoon Namkung, (unknown), (unknown), Yubo Cao, (unknown), Viktoriya Lukasheva, (unknown), (unknown), Jean‐Michel Longpré, Dominic Devost, Terence E. Hébert, Graciela Piñeyro, Richard Leduc, Cláudio M. Costa-Neto, Michel Bouvier, Stéphane A. Laporte	98
11	Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function 2017 ·PLoS ONE ·(unknown), Natalie J. Ronaghan, (unknown), Sébastien P. Dion, Antoine Désilets, Richard Leduc, Wallace K. MacNaughton	9
12	The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction 2016 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Natalie J. Ronaghan, (unknown), (unknown), Raza S. Zaheer, Pina Colarusso, Sébastien P. Dion, Antoine Désilets, Richard Leduc, Jerrold R. Turner, Wallace K. MacNaughton	23
13	Essential Role of Endocytosis of the Type II Transmembrane Serine Protease TMPRSS6 in Regulating Its Functionality 2011 ·Journal of Biological Chemistry ·François Béliveau, Cédric Brulé, Antoine Désilets, Brandon Zimmerman, Stéphane A. Laporte, Christine Lavoie, Richard Leduc	21
14	The Fifth Transmembrane Domain of Angiotensin II Type 1 Receptor Participates in the Formation of the Ligand-binding Pocket and Undergoes a Counterclockwise Rotation upon Receptor Activation 2009 ·Journal of Biological Chemistry ·(unknown), Stéphane Martin, Brian J. Holleran, (unknown), (unknown), Pierre Lavigne, Emanuel Escher, Richard Leduc, Gaétan Guillemette	15
15	Activation Induces Structural Changes in the Liganded Angiotensin II Type 1 Receptor 2009 ·Journal of Biological Chemistry ·(unknown), (unknown), Brian J. Holleran, Richard Leduc, Gaétan Guillemette, Pierre Lavigne, Emanuel Escher	12
16	Biological properties and functional determinants of the urotensin II receptor 2007 ·Peptides ·Christophe D. Proulx, Brian J. Holleran, Pierre Lavigne, Emanuel Escher, Gaétan Guillemette, Richard Leduc	32
17	Characterization of METH-1/ADAMTS1 Processing Reveals Two Distinct Active Forms 2000 ·Journal of Biological Chemistry ·Juan Carlos Rodríguez‐Manzaneque, (unknown), Erick K. Dufour, Richard Leduc, M. Luisa Iruela‐Arispe	130
18	Desensitization of AT1 Receptor-Mediated Cellular Responses Requires Long Term Receptor Down-Regulation in Bovine Adrenal Glomerulosa Cells* 1997 ·Endocrinology ·Darren E. Richard, Stéphane A. Laporte, Sylvie G. Bernier, Richard Leduc, Gaétan Guillemette	18
19	Processing of proendothelin‐1 by human furin convertase 1995 ·FEBS Letters ·Jean‐Bernard Denault, Audrey Claing, Pedro D’Orléans-Juste, Tatsuya Sawamura, Tsuneo Kido, Τοmoh Masaki, Richard Leduc	80
20	Presence of Furin mRNA in Cultured Bovine Endothelial Cells and Possible Involvement of Furin in the Processing of the Endothelin Precursor 1993 ·Journal of Cardiovascular Pharmacology ·Stéphane A. Laporte, Jean‐Bernard Denault, Pedro D’Orléans-Juste, Richard Leduc	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact